Current treatment of head and neck squamous cell cancer

Journal of Surgical Oncology

Volumn 110, Issue 5, 2014, Pages 551-574

  Belcher, Ryan ^a   Hayes, Katherine ^a   Fedewa, Stacey ^b   Chen, Amy Y ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

chemotherapy; head and neck; outcomes; radiation; squamous cell cancer; surgery

Indexed keywords

ALCOHOL CONSUMPTION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARBON DIOXIDE LASER; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ERYTHROPLASIA; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; LASER SURGERY; LEUKOPLAKIA; LIP CANCER; LYMPHATIC DRAINAGE; MANDIBLE RESECTION; MICROSURGERY; MOUTH SQUAMOUS CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL BIOPSY; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SMOKING; SUN EXPOSURE; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS;

EID: 84921730580     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23724     Document Type: Conference Paper

References (64)

1. American Cancer Society: Cancer facts & figures 2013. Atlanta, GA: American Cancer Society; 2013.
2. Silverman S, Jr.:, Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001; 132: 7S-11S.
3. Lopes V, Murray P, Williams H, et al.,: Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus. Oral Oncol 2011; 47: 698-701.
4. Silverman S, Jr., Gorsky M, Lozada F:, Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer 1984; 53: 563-568.
5. Wrangle JM, Khuri FM:, Chemoprevention of squamous cell carcinoma of the head and neck. Curr Opin Oncol 2007; 19: 180-187.
6. Madison MT, Remley KB, Latchaw RE, et al.,: Radiologic diagnosis and staging of head and neck squamous cell carcinoma. Radiol Clin North Am 1994; 32: 163-181.
7. Genden EM, Ferlito A, Silver CE, et al.,: Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol 2010; 267: 1001-1017.
8. Lefebvre JL, Coche-Dequeant B, Buisset E, et al.,: Management of early oral cavity cancer. Experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 1994; 30: 216-220.
9. Bernier J, Domenge C, Ozsahin M, et al.,: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952.
10. Cooper JS, Pajak TF, Forastiere AA, et al.,: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
11. Zhang H, Dziegielewski PT, Biron VL, et al.,: Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: A multi-institutional analysis. J Otolaryngol Head Neck Surg 2013; 19: 30-42.
12. Cohen EEW, Baru J, Huo D, et al.,: Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head and Neck 2009; 31: 1013-1021.
13. Gore SM, Crombie AK, Batstone MD, et al.,: Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma. Head Neck 2014. doi: 10.1002/hed.23626
14. Shah JP, Gil Z:, Current concepts in management of oral cancer-Surgery. Oral Oncol 2009; 45: 394-401.
15. Byers RM, Weber RS, Andrews T, et al.,: Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the tongue. Head Neck 1997; 19: 14-19.
16. Shin YS, Koh YW, Kim SH, et al.,: Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma. Yonsei Med J 2013; 54: 139-144.
17. Pugliano FA, Piccirillo JF, Zequeira MR, et al.,: Clinical-severity staging system for oral cavity cancer: Five-year survival rates. Otolaryngol Head Neck Surg 1999; 120: 138-145.
18. Goldenberg D, Lee J, Koch WM, et al.,: Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg 2004; 131: 986-993.
19. Gillison ML, Zhang Q, Jordan R, et al.,: Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012; 30: 2102-2111.
20. Mehanna H, Olaleye O, Licitra L:, Oropharyngeal cancer-Is it time to change management according to human papilloma virus status ? Curr Opin Otolaryngol Head Neck Surg 2012; 20: 120-124.
21. Mendenhall WM, Mancuso AA, Parsons JT, et al.,: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20: 739-744.
22. Moncrief M, Sandilla J, Clark J, et al.,: Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Laryngoscope 2009; 119: 307-311.
23. Garden AS, Asper JA, Morrison WH, et al.,: Is concurrent chemoradation the treatment of choice for all patients with stage III or IV head and neck carcinoma ? Cancer 2004; 100: 1171-1178.
24. Machtay M, Rosenthal DI, Hershock D, et al.,: Using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania Phase II Trial. J Clin Oncol 2002; 20: 3964-3971.
25. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690.
26. The NCCN Clinical Practice Guidelines in Oncology Head and Neck Cancers (Version 1.2014). National Comprehensive Cancer Network, Inc; 2014. Available at: http:NCCN.org. Accessed May 19, 2014.
27. Forastiere AA, Goepfert H, Maor M, et al.,: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Eng J Med 2003; 349: 2091-2098.
28. Lefebvre JL, Chevalier D, Luboinski B, et al.,: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial. J Natl Cancer Inst 1996; 88: 890-899.
29. Denis F, Garaud P, Bardet E, et al.,: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76.
30. Dziegielewski PT, Teknos TN, Durmus K, et al.,: Transoral robotic surgery for oropharyngeal cancer long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg 2013; 139: 1099-1108.
31. Bissada E, Brana I, Siu LL:, Important early advances in squamous cell carcinoma of the head and neck. Am Soc Clin Oncol Educ Book 2012; 32: 373-376.
32. Weinstein GS, O'Malley BW, Jr., Cohen MA, et al.,: Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136: 1079-1085.
33. Chung EJ, Oh JI, Choi KY, et al.,: Pattern of cervical lymph node metastasis in tonsil cancer: Predictive Factor analysis of contralateral and retropharyngeal lymph node metastasis. Oral Oncol 2011; 47: 758-762.
34. Pguliano FA, Piccirillo JF, Zequeria MR, et al.,: Clinical-severity staging system for oropharyngeal cancer: Five-year survival rates. Arch Otolaryngol Head Neck Surg 1997; 123: 1118-1124.
35. Fakhry C, Westra WH, Li S, et al.,: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
36. Ang KK, Harris J, Wheeler R, et al.,: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
37. Cooper JS, Porter K, Mallin K, et al.,: National Cancer Database report on cancer of the head and neck: 10-Year update. Head Neck 2009; 31: 748-758.
38. Lee YC, Marron M, Benhamou S, et al.,: Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study. Cancer Epidemiol Biomarkers Prev 2009; 119: 1274-1280.
39. Hoffman HT, Karnell LH, Funk GF, et al.,: The National Cancer Database report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 951-962.
40. Martin A, Jackel MC, Christiansen H, et al.,: Microsurgery for cancer of the hypopharynx. Laryngoscope 2008; 118: 398-402.
41. Koo BS, Lim YC, Lee JS, et al.,: Management of contralateral N0 neck in pyriform sinus carcinoma. Laryngoscope 2006; 116: 1268-1272.
42. Yoshimura R, Kagami Y, Ito Y, et al.,: Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2010; 77: 1017-1023.
43. Takes RP, Strojan P, Silver CE, et al.,: Current trends in initial management of hypopharyngeal cancer: the Declining use of open surgery. Head Neck 2012; 34: 270-281.
44. Park YM, Kim WS, Virgilio AD, et al.,: Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-Year oncologic and functional analysis. Oral Oncol 2012; 48: 560-566.
45. Pointreau Y, Garaud P, Chapet S, et al.,: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009; 101: 498-506.
46. Hall SF, Groome PA, Irish J, et al.,: The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 2008; 118: 1362-1371.
47. Kraus DH, Zelefsky MJ, Brock HAJ, et al.,: Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997; 116: 637-641.
48. Joo YH, Sun DI, Cho KJ, et al.,: The impact of paratracheal lymph node metastasis in squamous cell carcinoma of the hypopharynx. Eur Arch Otorhinolaryngol 2010; 267: 945-950.
49. Martin AS:, Neck and mediastinal node dissection in pharyngolaryngoesophageal tumors. Head Neck 2001; 23: 772-779.
50. Godballe C, Jorgensen K, Hansen O, et al.,: Hypopharyngeal cancer: Results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002; 112: 834-838.
51. Steiner W, Ambrosch P, Hess CF, et al.,: Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 2001; 124: 58-67.
52. Chen AY, Fedewa S, Zhu J:, Temporal trends in the treatment of early and advanced-stage laryngeal cancer in the United States 1985-2007. Arch Otolaryngol Head Neck Surg 2011; 137: 1017-1024.
53. Baumann JL, Cohen S, Evjen AN, et al.,: Human papillomavirus in early larngeal carcinoma. Laryngoscope 2009; 119: 1531-1537.
54. Sturgis EM, Cinciripini PM:, Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers. Cancer 2007; 110: 1429-1435.
55. Kreimer AR, Clifford GM, Boyle P, et al.,: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
56. Hoffman HT, Porter K, Karnell LH, et al.,: Laryngeal cancer in the United States changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
57. Gourin CG, Conger BT, Sheils C, et al.,: The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
58. Scola B, Fernandez-Vega M, Martinez T, et al.,: Mangement of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001; 124: 195-198.
59. Grant DG, Repanos C, Malpas G, et al.,: Transoral laser microsurgery for early laryngeal cancer. Expert Rev Anticancer Ther 2010; 10: 331-338.
60. Chen AY, Halpern M:, Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1270-1276.
61. Yuce I, Cagli S, Bayram A, et al.,: Occult metastases from T1-T2 supraglottic carcinoma: Role of primary tumor localization. Eur Arch Otorhinolaryngol 2009; 266: 1301-1304.
62. Cosetti M, Yu G, Schantz SP:, Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 2008; 134: 370-379.
63. Chen AY, Fedewa S, Pavluck A, et al.,: Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 2011; 116: 4744-4752.
64. Zhu J, Fedewa S, Chen A:, The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic, laryngeal cancer. Arch Otolaryngol 2012; 138: 1120-1128.